Shizuoka, Japan

Jinki Hadano

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinki Hadano. Retrieved from https://idiyas.com/inventor/jinki-hadano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jinki Hadano: Innovator in Antibody Research

Introduction

Jinki Hadano is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work focuses on creating innovative solutions that address critical health challenges.

Latest Patents

Jinki Hadano holds a patent for an "Antibody for Neutralizing Substance Having Coagulation Factor VIII (F.VIII) Function-Substituting Activity." This patent represents her commitment to advancing medical science and improving treatment options for patients with coagulation disorders.

Career Highlights

Throughout her career, Jinki has been associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. Her role at the company has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Due to space constraints, the details of her collaborations will not be included.

Conclusion

Jinki Hadano's innovative work in antibody research exemplifies her dedication to improving healthcare through scientific advancements. Her contributions continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…